Cited by 333Cancer Mechanisms and TherapyComputational Drug Discovery MethodsMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 326 of the 333 references it cites were found in a registry or an index.

Drug repurposing in cancer

Sleire, Linda, Førde, Hilde Elise, Netland, Inger Anne, Leiss, Lina, Skeie, Bente Sandvei, Enger, Per Øyvind·2017·Pharmacological Research

DOI 10.1016/j.phrs.2017.07.013

Open this paper in CoChat — free account

Abstract

Cancer is a major health issue worldwide, and the global burden of cancer is expected to increase in the coming years. Whereas the limited success with current therapies has driven huge investments into drug development, the average number of FDA approvals per year has declined since the 1990s. This unmet need for more effective anti-cancer drugs has sparked a growing interest for drug repurposing, i.e. using drugs already approved for other indications to treat cancer. As such, data both from pre-clinical experiments, clinical trials and observational studies have demonstrated anti-tumor efficacy for compounds within a wide range of drug classes other than cancer. Whereas some of them induce cancer cell death or suppress various aspects of cancer cell behavior in established tumors, others may prevent cancer development. Here, we provide an overview of promising candidates for drug repurposing in cancer, as well as studies describing the biological mechanisms underlying their anti-neoplastic effects.

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2017.07.013

Cites

326 of 326 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
Ettinger, B. (1999) · JAMA · doi:10.1001/jama.282.7.637 · Cited by 3,366
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,334
World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015
McGuire, S. (2016) · Advances in Nutrition · doi:10.3945/an.116.012211 · Cited by 1,900
The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes<SUBTITLE>The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial</SUBTITLE>
Vogel, V. G. (2006) · JAMA · doi:10.1001/jama.295.23.joc60074 · Cited by 1,652
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
The renaissance of GSK3
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., Rodríguez, L. A. G., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,223
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-Analysis
Larsson, S. C., Orsini, N., & Wolk, A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji375 · Cited by 1,038
Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status
Hardie, D. G. (2003) · Endocrinology · doi:10.1210/en.2003-0982 · Cited by 994
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
The sympathetic nervous system induces a metastatic switch in primary breast cancer
Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0522 · Cited by 930
Estimating The Cost Of New Drug Development: Is It Really $802 Million?
Adams, C., & Brantner, V. V. (2006) · Health Affairs · doi:10.1377/hlthaff.25.2.420 · Cited by 917
NF-κB as a Therapeutic Target in Multiple Myeloma
Hideshima, T., Chauhan, D., Richardson, P. G. G., Mitsiades, C. S., Mitsiades, N., Hayashi, T., Munshi, N. C., Dang, L., Castro, A. C., Palombella, V. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200360200 · Cited by 899
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 884
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
Bibbins-Domingo, K. B., & on behalf of the U.S. Preventive Services Task Force* (2016) · Annals of Internal Medicine · doi:10.7326/m16-0577 · Cited by 864
AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling
Bolster, D. R., Crozier, S. J., Kimball, S. R., & Jefferson, L. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200171200 · Cited by 851
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 833
The role of hypoxia-inducible factors in tumorigenesis
Rankin, E. B., & Giaccia, A. J. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.21 · Cited by 806 · cited 1×
“increased in tumors, and are associated with a worse prognosis (78).”
Background
The effect of raloxifene on risk of breast cancer in postmenopausal women : results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
Cummings, S. R. (1999) · Medical Entomology and Zoology · Cited by 797
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan, A. T., Ogino, S., & Fuchs, C. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067208 · Cited by 776
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Cuzick, J. M., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J. A., Vecchia, C. L., Meyskens, F. L., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 713
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M. (2014) · Nature · doi:10.1038/nature13110 · Cited by 710
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
Hawley, S. A., Gadalla, A. E., Olsen, G. S., & Hardie, D. G. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2420 · Cited by 696
Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene
Martino, S., Cauley, J. A., Barrett-Connor, E., Powles, T. J., Mershon, J., Disch, D., Secrest, R. J., Cummings, S. R., & For the CORE Investigators (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh319 · Cited by 684
Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 683
Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial
Cauley, J. A., Norton, L., Lippman, M. E., Eckert, S., Krueger, K. A., Purdie, D. W., Farrerons, J., Karasik, A., Mellstrom, D., Ng, K. W., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006478317173 · Cited by 678
Neural plasticity to stress and antidepressant treatment
Duman, R. S., Malberg, J. E., & Thome, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00177-8 · Cited by 648
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0076 · Cited by 644
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809763105 · Cited by 624 · cited 1×
“eradicate established xenograft tumors by suppressing HIF-1α and HIF-2α expression (77).”
Background
Thalidomide
FRANKS, M. E., Macpherson, G. R., & Figg, W. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16308-3 · Cited by 616
The statins as anticancer agents.
Chan, K., Oza, A. M., & Siu, L. L. (2003) · PubMed · Cited by 607
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
Wong, W. W.-L., Dimitroulakos, J., Minden, M., & Penn, L. Z. (2002) · Leukemia · doi:10.1038/sj.leu.2402476 · Cited by 587
The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor Therapy
Murata, H., Hruz, P. W., & Mueckler, M. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000228200 · Cited by 579
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
Friberg, E., Orsini, N., Mantzoros, C. S., & Wolk, A. (2007) · Diabetologia · doi:10.1007/s00125-007-0681-5 · Cited by 577
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
Kim, J., Tang, J. Y., Gong, R., Kim, J., Lee, J. J., Clemons, K. V., Chong, C. R., Chang, K. S., Fereshteh, M., Gardner, D., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.027 · Cited by 527
Arachidonic Acid Oxygenation by COX-1 and COX-2
Marnett, L. J., Rowlinson, S. W., Goodwin, D. C., Kalgutkar, A. S. S., & Lanzo, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.22903 · Cited by 524
Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of Drugs
Golub, L. M., Ramamurthy, N. S., McNamara, T. F., Greenwald, R. A., & Rifkin, B. R. (1991) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411910020030201 · Cited by 523
Molecular Targets of Lithium Action
Phiel, C. J., & Klein, P. S. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.789 · Cited by 521
Aspirin and Risk of Hemorrhagic Stroke
He, J., Whelton, P. K., Vu, B., & Klag, M. J. (1998) · JAMA · doi:10.1001/jama.280.22.1930 · Cited by 518
The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
Sobolewski, C., Cerella, C., Dicato, M. A., Ghibelli, L., & Diederich, M. F. (2010) · International Journal of Cell Biology · doi:10.1155/2010/215158 · Cited by 493
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
Melhem‐Bertrandt, A., Chávez‐MacGregor, M., Lei, X. J., Brown, E. N., Lee, R. T., Meric‐Bernstam, F., Sood, A. K., Conzen, S. D., Hortobágyi, G. N., & Gonzalez-Angulo, A. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4441 · Cited by 471
Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis
Horman, S., Browne, G. J., Krause, U., Patel, J. V., Vertommen, D., Bertrand, L., Lavoinne, A., Hue, L., Proud, C. G., & Rider, M. H. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01077-1 · Cited by 467
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
Powe, D. G., Voss, M. J., Zänker, K. S., Habashy, H. O., Green, A. R., Ellis, I. O., & Entschladen, F. (2010) · Oncotarget · doi:10.18632/oncotarget.197 · Cited by 462
Aspirin and colorectal cancer: the promise of precision chemoprevention
Drew, D. A., Cao, Y., & Chan, A. T. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.4 · Cited by 458
Metformin directly acts on mitochondria to alter cellular bioenergetics
Andrzejewski, S., Gravel, S., Pollak, M., & St‐Pierre, J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-12 · Cited by 437
A review of thalidomide's history and current dermatological applications
Perri, A. J., & Hsu, S. (2003) · Dermatology Online Journal · doi:10.5070/d35fk5w0qv · Cited by 432
Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
Franciosi, M., Lucisano, G., Lapice, E., Strippoli, G. F. M., Pellegrini, F., & Nicolucci, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071583 · Cited by 428
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells
Marzano, C., Gandin, V., Folda, A., Scutari, G., Bindoli, A., & Rigobello, M. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.021 · Cited by 420
Norepinephrine Up-regulates the Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinase (MMP)-2, and MMP-9 in Nasopharyngeal Carcinoma Tumor Cells
Yang, E. V., Sood, A. K., Chen, M., Li, Y., Eubank, T. D., Marsh, C. B., Jewell, S., Flavahan, N. A., Morrison, C., Yeh, P.-E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2496 · Cited by 407
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Huang, X., Wullschleger, S., Shpiro, N., McGuire, V. A., Sakamoto, K., Woods, Y. L., Mcburnie, W., Fleming, S., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080557 · Cited by 396
Discovery, mechanisms of action and combination therapy of artemisinin
Cui, L., & Su, X. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.68 · Cited by 385
The Status of Disulfiram: A Half of a Century Later
Suh, J. J., Pettinati, H. M., Kampman, K. M., & O'Brien, C. P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222512.25649.08 · Cited by 382
Treatment of Osteosarcoma
PORTER, K. A., CALNE, R. Y., & ZUKOSKI, C. F. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90940-7 · Cited by 369
Role of prostaglandin E 2 -dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
Chang, S.-H., Liu, C. H., Conway, R. E., Han, D. K. M., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535911100 · Cited by 361
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Kordes, S., Pollak, M. N., Zwinderman, A. H., Mathôt, R. A., Weterman, M. J., Beeker, A., Punt, C. J., Richel, D. J., & Wilmink, J. W. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00027-3 · Cited by 361
Cancer drug discovery by repurposing: teaching new tricks to old dogs
Gupta, S. C., Sung, B., Prasad, S., Webb, L. J., & Aggarwal, B. B. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.06.005 · Cited by 355
Resolvins, docosatrienes, and neuroprotectins, novel omega‐3‐derived mediators, and their endogenous aspirin‐triggered epimers
Serhan, C. N., Arita, M., Hong, S., & Gotlinger, K. H. (2004) · Lipids · doi:10.1007/s11745-004-1339-7 · Cited by 355
Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
Higurashi, T., Hosono, K., Takahashi, H., Komiya, Y., Umezawa, S., Sakai, E., Uchiyama, T., Taniguchi, L., Hata, Y., Uchiyama, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00565-3 · Cited by 335
Antipyretics: mechanisms of action and clinical use in fever suppression
Aronoff, D. M., & Neilson, E. G. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00834-8 · Cited by 327
Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo
Gills, J. J., LoPiccolo, J., Tsurutani, J., Shoemaker, R. H., Best, C. J. M., Abu-Asab, M. S., Borojerdi, J. P., Warfel, N. A., Gardner, E. R., Danish, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0161 · Cited by 322
Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
Hou, J., Wang, D., Zhang, R., & Wang, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0197 · Cited by 319
Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation
Takada, Y., Bhardwaj, A., Potdar, P. D., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 309
Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers.
Masur, K., Niggemann, B., Zänker, K. S., & Entschladen, F. (2001) · PubMed · Cited by 308
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Sadeghi, N., Abbruzzese, J. L., Yeung, S. J., Hassan, M. M., & Li, D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2994 · Cited by 308
Diabetes mellitus and risk of bladder cancer: a meta-analysis
Larsson, S. C., Orsini, N., Brismar, K., & Wolk, A. (2006) · Diabetologia · doi:10.1007/s00125-006-0468-0 · Cited by 304
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
Mirabelli, C. K., Johnson, R. K., Sung, C. M., Faucette, L. F., Muirhead, K. A., & Crooke, S. T. (1985) · PubMed · Cited by 295
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
Hadad, S. M., Iwamoto, T., Jordan, L. B., Purdie, C. A., Bray, S. E., Baker, L., Jellema, G. L., Deharo, S., Hardie, D. G., Pusztai, L., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1612-1 · Cited by 293
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
Kim, D. J., Kim, J., Spaunhurst, K., Montoya, J., Khodosh, R., Chandra, K., Fu, T., Gilliam, A., Molgo, M., Beachy, P. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.9525 · Cited by 289
Cancer Drugs in the United States: Justum Pretium—The Just Price
Kantarjian, H. M., Fojo, T., Mathisen, M. S., & Zwelling, L. A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1845 · Cited by 285
Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent
Pantziarka, P. (2014) · ecancermedicalscience · doi:10.3332/ecancer.2014.485 · Cited by 280
Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells.
McConkey, D. J., Lin, Y., Nutt, L. K., Ozel, H. Z., & Newman, R. A. (2000) · PubMed · Cited by 280
Statin use and cancer risk: a comprehensive review
Boudreau, D. M., Yu, O., & Johnson, J. (2010) · Expert Opinion on Drug Safety · doi:10.1517/14740331003662620 · Cited by 279
A DRUG SENSITISING THE ORGANISM TO ETHYL ALCOHOL
Hald, J., & Jacobsen, E. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91514-1 · Cited by 277
Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2.
Pugh, S., & Thomas, G. A. O. (1994) · Gut · doi:10.1136/gut.35.5.675 · Cited by 270
Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia
Fiskus, W. C., Saba, N. S., Shen, M., Ghias, M. H., Liu, J., Gupta, S. D., Chauhan, L., Rao, R., Gunewardena, S., Schorno, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2033 · Cited by 251
Angiogenesis inhibition by minocycline.
Tamargo, R. J., Bok, R., & Brem, H. (1991) · PubMed · Cited by 250
Inhibition of Angiogenesis by the Antifungal Drug Itraconazole
Chong, C. R., Xu, J., Lu, J., Bhat, S., Sullivan, D. J., & Liu, J. O. (2007) · ACS Chemical Biology · doi:10.1021/cb600362d · Cited by 210
Digitalis-Induced Signaling by Na+/K+-ATPase in Human Breast Cancer Cells
Kometiani, P., Liu, L., & Askari, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007302 · Cited by 208
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
He, X., Esteva, F. J., Ensor, J., Hortobágyi, G. N., Lee, M., & Yeung, S. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr534 · Cited by 206
Distinct perturbation of the translatome by the antidiabetic drug metformin
Larsson, O. S., Morita, M., Topisirović, I., Alain, T., Blouin, M., Pollak, M., & Sonenberg, N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201689109 · Cited by 205
Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme
Bai, R.-Y., Staedtke, V., Aprhys, C. M., Gallia, G. L., & Riggins, G. J. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor077 · Cited by 201
Management of thalidomide toxicity.
Ghobrial, I. M., & Rajkumar, S. V. (2003) · PubMed · Cited by 196
Potential applications for biguanides in oncology
Pollak, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67232 · Cited by 194
Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo
Fan, C., Zheng, W., Fu, X., Li, X., Wong, Y.-S., & Chen, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.132 · Cited by 193
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate Cancer
Antonarakis, E. S., Heath, E. I., Smith, D. C., Rathkopf, D., Blackford, A. L., Danila, D. C., King, S., Frost, A., Ajiboye, A. S., Zhao, M., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-314 · Cited by 180
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
Romero, I. L., McCormick, A., McEwen, K. A., Park, S., Karrison, T. G., Yamada, S. D., Pannain, S., & Lengyel, E. R. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182393ab3 · Cited by 178
Itraconazole suppresses the growth of glioblastoma through induction of autophagy: Involvement of abnormal cholesterol trafficking
Liu, R., Li, J., Zhang, T., Zou, L., Chen, Y., Wang, K., Lei, Y., Yuan, K., Li, Y., Lan, J., et al. (2014) · Autophagy · doi:10.4161/auto.28912 · Cited by 178
Untitled work
(2002) · PubMed · Cited by 177
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
Liu, N., Li, X., Huang, H., Zhao, C., Liao, S., Yang, C., Liu, S., Song, W., Lan, X., Lan, X., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2113 · Cited by 175
The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms
Elder, R. T., Xu, X., Williams, J. W., Gong, H., Finnegan, A., & Chong, A. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.22 · Cited by 174
ecancermedicalscience
Pantziarka, P., Bouche, G., Meheus, L., Sukhatme, V. V., Sukhatme, V. P., & Vikas, P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2014.442 · Cited by 173
Differential Induction of Apoptosis by Antidepressants in Glioma and Neuroblastoma Cell Lines: Evidence for p-c-Jun, Cytochrome c, and Caspase-3 Involvement
Levkovitz, Y., Gil‐Ad, I., Zeldich, E., Dayag, M., & Weizman, A. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:029 · Cited by 172
Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines.
Elder, D. J. E., Hague, A., Hicks, D. J., & Paraskeva, C. (1996) · PubMed · Cited by 172
Untitled work
(2002) · PubMed · Cited by 170
Itraconazole Inhibits Angiogenesis and Tumor Growth in Non–Small Cell Lung Cancer
Aftab, B. T., Dobromilskaya, I., Liu, J. O., & Rudin, C. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0691 · Cited by 167
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Nishihara, R., Lochhead, P. J., Kuchiba, A., Jung, S., Yamauchi, M., Liao, X., Imamura, Y., Qian, Z. R., Morikawa, T., Wang, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6599 · Cited by 166
Cancer incidence in the multicenter aids cohort study before and during the HAART era
Seaberg, E. C., Wiley, D. J., Martı́nez-Maza, O., Chmiel, J. S., Kingsley, L., Tang, Y., Margolick, J. B., & Jacobson, L. P. (2010) · Cancer · doi:10.1002/cncr.25530 · Cited by 162
Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non‐antimicrobial tetracycline analog (COL‐3) in a metastatic prostate cancer model
Lokeshwar, B. L., Selzer, M. G., Zhu, B., Block, N. L., & Golub, L. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.10168 · Cited by 161
Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide
Mattar, T., Kochhar, K. S., Bartlett, R. R., Bremer, E. G., & Finnegan, A. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81704-4 · Cited by 155
Nelfinavir Down-regulates Hypoxia-Inducible Factor 1α and VEGF Expression and Increases Tumor Oxygenation: Implications for Radiotherapy
Pore, N., Gupta, A., Cerniglia, G. J., Jiang, Z., Bernhard, E. J., Evans, S. M., Koch, C. J., Hahn, S. M., & Maity, A. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1239 · Cited by 154
Dihydroartemisinin Is Cytotoxic to Papillomavirus-Expressing Epithelial Cells In vitro and In vivo
Disbrow, G. L., Baege, A. C., Kierpiec, K. A., Yuan, H., Centeno, J. A., Thibodeaux, C. A., Hartmann, D., & Schlegel, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1216 · Cited by 154
The discovery of aspirin's antithrombotic effects.
Miner, J. J., & Hoffhines, A. J. (2007) · PubMed · Cited by 153
Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
Garrett, C. R., Hassabo, H. M., Bhadkamkar, N. A., Wen, S., Baladandayuthapani, V., Kee, B. K., Eng, C., & Hassan, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.71 · Cited by 153
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
He, X., Tu, S., Lee, M., & Yeung, S. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr020 · Cited by 153
Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells
Doudican, N., Rodriguez, A., Osman, I., & Orlow, S. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2159 · Cited by 152
Raloxifene
Clemett, D., & Spencer, C. M. (2000) · Drugs · doi:10.2165/00003495-200060020-00013 · Cited by 150
The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt/mTOR pathway in human U-87MG glioma cells
Shin, S. Y., Lee, K. S., Choi, Y., Lim, H. J., Lee, M. H., Lim, Y., & Lee, Y. H. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt169 · Cited by 149
Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer
Rudin, C. M., Brahmer, J. R., Juergens, R. A., Hann, C. L., Ettinger, D. S., Sebree, R., Smith, R. D., Aftab, B. T., Huang, P., & Liu, J. O. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828c3950 · Cited by 148
Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
Dalva-Aydemir, S., Bajpai, R., Martinez, M. S., Adekola, K., Kandela, I. K., Wei, C., Singhal, S., Koblinski, J. E., Raje, N. S., Rosen, S. T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1088 · Cited by 145
Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
Berger, J. S., Lala, A., Krantz, M. J., Baker, G. S., & Hiatt, W. R. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.04.006 · Cited by 145
Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies
Wu, L., Zhu, J., Prokop, L. J., & Murad, M. H. (2015) · Scientific Reports · doi:10.1038/srep10147 · Cited by 144
Prophylactic Use of NSAIDs by Athletes: A Risk/Benefit Assessment
Warden, S. J. (2010) · The Physician and Sportsmedicine · doi:10.3810/psm.2010.04.1770 · Cited by 144
A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
Tejman-Yarden, N., Miyamoto, Y., Leitsch, D., Santini, J., Debnath, A., Gut, J., McKerrow, J. H., Reed, S. L., & Eckmann, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01675-12 · Cited by 144
Diabetes and Risk of Non-Hodgkin's Lymphoma
Mitri, J., Castillo, J. J., & Pittas, A. G. (2008) · Diabetes Care · doi:10.2337/dc08-1034 · Cited by 140
HIV-1 Protease Inhibitors Nelfinavir and Atazanavir Induce Malignant Glioma Death by Triggering Endoplasmic Reticulum Stress
Pyrko, P., Kardosh, A., Wang, W., Xiong, W., Schönthal, A. H., & Chen, T. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0796 · Cited by 140
Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes
Zhelev, Z., Ohba, H., Bakalova, R., Hadjimitova, V. A., Ishikawa, M., Shinohara, Y., & Baba, Y. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0738-1 · Cited by 138
ANTI-METASTATIC EFFECT OF ASPIRIN
Gasic, G. J., Gasic, T. B., & Murphy, S. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92581-0 · Cited by 138
Two activities of the immunosuppressive metabolite of leflunomide, A77 1726
Xu, X., Williams, J. W., Gong, H., Finnegan, A., & Chong, A. S. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00303-6 · Cited by 138
Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
Guo, X., Xu, B., Pandey, S., Goessl, E., Brown, J. E. P., Armesilla, A. L., Darling, J. L., & Wang, W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.002 · Cited by 136
Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade
Partecke, L. I., Speerforck, S., Käding, A., Seubert, F., Kühn, S., Lorenz, E., Schwandke, S., Sendler, M., Keßler, W., Trung, D. N., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.03.005 · Cited by 136
Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
Nygren, P., Fryknäs, M., Ågerup, B., & Larsson, R. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1539-5 · Cited by 133
MDA-7/IL-24 is a unique cytokine–tumor suppressor in the IL-10 Family
Chada, S., Sutton, R. B., Ekmekçioglu, S., Ellerhorst, J. A., Mumm, J. B., Leitner, W. W., Yang, H.-Y., Şahin, A. A., Hunt, K. K., Fuson, K. L., et al. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.017 · Cited by 132
Thalidomide in cancer
Singhal, S., & Mehta, J. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00146-9 · Cited by 132
The Antifungal Drug Itraconazole Inhibits Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Glycosylation, Trafficking, and Signaling in Endothelial Cells
Nacev, B. A., Grassi, P., Dell, A., Haslam, S. M., & Liu, J. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.278754 · Cited by 130
Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells
Zhou, H., Wang, W., Wu, G.-D., Lee, J. H., & Li, A. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.05.002 · Cited by 129
Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer
Srirangam, A., Mitra, R., Wang, M., Gorski, J. C., Badve, S., Baldridge, L., Hamilton, J., Kishimoto, H., Hawes, J. W., Li, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1167 · Cited by 126
Inhibition of DNA Topoisomerases I and II, and Growth Inhibition of Breast Cancer MCF-7 Cells by Ouabain, Digoxin and Proscillaridin A
Bielawski, K., Winnicka, K., & Bielawska, A. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1493 · Cited by 126
Digitoxin and its analogs as novel cancer therapeutics
Elbaz, H. A., Stueckle, T. A., Tse, W. W., Rojanasakul, Y., & Dinu, C. Z. (2012) · Experimental Hematology and Oncology · doi:10.1186/2162-3619-1-4 · Cited by 124
Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.
Duivenvoorden, W., Popović, S., Lhoták, Š., Seidlitz, E. P., Hirte, H. W., Tozer, R. G., & Singh, G. (2002) · PubMed · Cited by 124
Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)
Rothermundt, C. A., Hayoz, S., Templeton, A. J., Winterhalder, R., Strebel, R. T., Bärtschi, D., Pollak, M., Lui, L., Endt, K., Schiess, R., et al. (2014) · European Urology · doi:10.1016/j.eururo.2013.12.057 · Cited by 123
Cancer risk among users of neuroleptic medication: a population-based cohort study
Dalton, S. O., Johansen, C., Poulsen, A. H., Nørgaard, M., Sørensen, H. T., McLaughlin, J. K., Mortensen, P. B., & Friis, S. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603259 · Cited by 123
2016 FDA drug approvals
Mullard, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.14 · Cited by 121
Digitalis toxicity: Epidemiology and clinical use of serum concentration measurements
Smith, T. W. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90118-7 · Cited by 120
Statins and the risk of colorectal cancer: An updated systematic review and meta-analysis of 40 studies
Lytras, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1858 · Cited by 119
Repurposing Drugs in Oncology (ReDO)—diclofenac as an anti-cancer agent
Pantziarka, P., Sukhatme, V. V., Bouche, G., Melhuis, L., & Sukhatme, V. P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.610 · Cited by 119
Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage
Paranjpe, A., Zhang, R., Ali‐Osman, F., Bobustuc, G. C., & Srivenugopal, K. S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt366 · Cited by 118
Inhibition of proliferation and induction of apoptosis by doxycycline in cultured human osteosarcoma cells
Fife, R. S., Rougraff, B. T., Proctor, C., & Sledge, G. W. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90130-x · Cited by 116
Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment
Pollak, M. (2014) · Nature Medicine · doi:10.1038/nm.3596 · Cited by 115
The Novel Combination of Chlorpromazine and Pentamidine Exerts Synergistic Antiproliferative Effects through Dual Mitotic Action
Lee, M. S., Johansen, L. M., Zhang, Y., Wilson, A., Keegan, M., Avery, W., Elliott, P. J., Borisy, A. A., & Keith, C. T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2235 · Cited by 115
Metformin use and improved response to therapy in esophageal adenocarcinoma
Skinner, H. D., McCurdy, M. R., Echeverria, A. E., Lin, S. H., Welsh, J. W., O’Reilly, M. S., Hofstetter, W. L., Ajani, J. A., Komaki, R. R., Cox, J. D., et al. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.718096 · Cited by 112
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells
Baumann, P., Mandl–Weber, S., Völkl, A., Adam, C., Bumeder, I., Oduncu, F. S., & Schmidmaier, R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0664 · Cited by 112
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase ( HPGD )
Fink, S. P., Yamauchi, M., Nishihara, R., Jung, S., Kuchiba, A., Wu, K., Cho, E., Giovannucci, E. L., Fuchs, C. S., Ogino, S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008481 · Cited by 111
Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts
Leclerc, G. M., Leclerc, G. J., Kuznetsoff, J. N., DeSalvo, J., & Barredo, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074420 · Cited by 111
Cu/Zn superoxide dismutase plays a role in angiogenesis
Marikovsky, M., Nevo, N., Vadai, E., & Harris‐Cerruti, C. (2001) · International Journal of Cancer · doi:10.1002/ijc.1565 · Cited by 110
Transcriptional regulation of cyclo-oxygenase expression: three pillars of control.
Ramsay, R. G., Ciznadija, D., Vanevski, M., & Mantamadiotis, T. (2003) · PubMed · Cited by 109
Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients
Wickström, M., Danielsson, K., Rickardson, L., Gullbo, J., Nygren, P., Isaksson, A., Larsson, R. L., & Lövborg, H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.016 · Cited by 109
Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation
Chen, T., Lin, C., Huang, P., & Wen, C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06664.x · Cited by 107
Inhibition of Invasion and Angiogenesis by Zinc-Chelating Agent Disulfiram
Shian, S.-G., Kao, Y.-R., Wu, F. Y.-H., & Wu, C. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1076 · Cited by 106
Penfluridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis
Ranjan, A., Gupta, P., & Srivastava, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1233 · Cited by 105
Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells.
Hixson, L. J., Alberts, D. S., Krutzsch, M. F., Einsphar, J., Brendel, K., Gross, P. H., Paranka, N. S., Baier, M. L., Emerson, S. S., & Pamukcu, R. (1994) · PubMed · Cited by 105
Metformin use and improved response to therapy in rectal cancer
Skinner, H. D., Crane, C. H., Garrett, C. R., Eng, C., Chang, G. J., Skibber, J. M., Rodrı́guez-Bigas, M. A., Kelly, P., Sandulache, V. C., Delclos, M. E., et al. (2013) · Cancer Medicine · doi:10.1002/cam4.54 · Cited by 103
Repurposing of approved cardiovascular drugs
Ishida, J., Konishi, M., Ebner, N., & Springer, J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1031-5 · Cited by 103
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer
Laskov, I., Drudi, L. M., Beauchamp, M.-C., Yasmeen, A., Ferenczy, A. S., Pollak, M., & Gotlieb, W. H. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.06.014 · Cited by 103
Chromosome changes in 17 human neoplasms studied with banding
Riet-Fox, M. F. D. V., Retief, A. E., & Niekerk, W. A. V. (1979) · Cancer · doi:10.1002/1097-0142(197912)44:6 · Cited by 103
Inhibition of tubulin polymerization by Mebendazole
Laclette, J. P., Guerra, G., & Zetina, C. R. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)90349-6 · Cited by 102
Sodium pump inhibition, enhanced calcium influx via sodium-calcium exchange, and positive inotropic response in cultured heart cells.
Barry, W. H., Hasin, Y., & Smith, T. W. (1985) · Circulation Research · doi:10.1161/01.res.56.2.231 · Cited by 102
Role of Aspirin in Cancer Prevention
Thorat, M. A., & Cuzick, J. M. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0351-3 · Cited by 101
Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer
Yang, J., Wei, J., Wu, Y., Wang, Z., Guo, Y., Lee, P. J., & Li, X. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.18 · Cited by 101
Dose–response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies
McQuay, H. J., & Moore, R. A. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02723.x · Cited by 99
Chlorimipramine: A novel anticancer agent with a mitochondrial target
Daley, E., Wilkie, D., Loesch, A., Hargreaves, I. P., Kendall, D. A., Pilkington, G. J., & Bates, T. E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.028 · Cited by 98
Repurposing the Antihelmintic Mebendazole as a Hedgehog Inhibitor
Larsen, A. R., Bai, R.-Y., Chung, J., Borodovsky, A., Rudin, C. M., Riggins, G. J., & Bunz, F. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0755-t · Cited by 98
Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
Hadad, S. M., Coates, P. J., Jordan, L. B., Dowling, R. J. O., Chang, M. C., Done, S. J., Purdie, C. A., Goodwin, P. J., Stambolic, V., Moulder-Thompson, S. L., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3307-5 · Cited by 97
The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation
Xia, Z., Bergstrand, A., DePierre, J. W., & N�ssberger, L. (1999) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/(sici)1099-0461(1999)13:6 · Cited by 97
Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation
Sikka, A., Kaur, M., Agarwal, C., Deep, G., & Agarwal, R. (2012) · Cell Cycle · doi:10.4161/cc.19798 · Cited by 96
Dihydroartemisinin induces autophagy and inhibits the growth of iron‐loaded human myeloid leukemia K562 cells via ROS toxicity
Wang, Z., Hu, W., Zhang, J., Wu, X., & Zhou, H. (2012) · FEBS Open Bio · doi:10.1016/j.fob.2012.05.002 · Cited by 95
Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70
Endo, H., Yano, M., Okumura, Y., & Kido, H. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.550 · Cited by 95
2015 FDA drug approvals
Mullard, A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.15 · Cited by 94
Drug Repurposing for Gastrointestinal Stromal Tumor
Pessetto, Z. Y., Weir, S. J., Sethi, G., Broward, M. A., & Godwin, A. K. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0968 · Cited by 94
Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells
Kumar, S., Bryant, C. S., Chamala, S., Qazi, A. M., Seward, S. M., Pal, J., Steffes, C. P., Weaver, D. W., Morris, R. T., Malone, J. M., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-26 · Cited by 92
Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality
McCowan, C., Munro, A. J., Donnan, P. T., & Steele, R. J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.10.024 · Cited by 91
HIV‐1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling
Yang, Y., Ikezoe, T., Takeuchi, T., Adachi, Y., Ohtsuki, Y., Takeuchi, S., Koeffler, H. P., & Taguchi, H. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00063.x · Cited by 91
Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells.
Palayoor, S. T., Bump, E. A., Calderwood, S. K., Bartol, S., & Coleman, C. N. (1998) · PubMed · Cited by 91
Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients
Mortensen, P. B. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb10325.x · Cited by 90
Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells
Onoda, T., Ono, T., Dhar, D. K., Yamanoi, A., Fujii, T., & Nagasue, N. (2004) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2003.12.012 · Cited by 90
Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K
Kim, M.-S., Kim, J., Lim, D. Y., Huang, Z., Chen, H., Langfald, A., Lubet, R. A., Grubbs, C. J., Dong, Z., & Bode, A. M. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0288 · Cited by 89
Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus.
Miller, M. T. (1991) · PubMed · Cited by 85
Effects of doxycycline on human prostate cancer cells in vitro
Fife, R. S., Sledge, G. W., Roth, B. J., & Proctor, C. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00003-2 · Cited by 85
Dihydroartemisinin Exerts Its Anticancer Activity through Depleting Cellular Iron via Transferrin Receptor-1
Ba, Q., Zhou, N., Duan, J., Chen, T., Hao, M., Yang, X., Li, J., Yin, J., Chu, R., & Wang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042703 · Cited by 84
Thalidomide and its derivatives: emerging from the wilderness
Gordon, J., & Goggin, P. M. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.929.127 · Cited by 84
The serotonin transporter (SLC6A4) is present in B‐cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics
Meredith, E. J., Holder, M. J., Chamba, A., Challa, A., Lee, A. D., Bunce, C. M., Drayson, M. T., Pilkington, G. J., Blakely, R., Dyer, M. J. S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3477fje · Cited by 83
In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug
Shi, X., Li, H., Yao, H., Liu, X., Li, L., Leung, K., Kung, H., Lu, D., Wong, M., & Lin, M. C. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132072 · Cited by 83
Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer
Nygren, P., & Larsson, R. (2014) · Acta Oncologica · doi:10.3109/0284186x.2013.844359 · Cited by 83
Cardiac Glycosides Induce Cell Death in Human Cells by Inhibiting General Protein Synthesis
Perné, A., Muellner, M. K., Steinrueck, M., Craig-Mueller, N., Mayerhofer, J., Schwarzinger, I., Sloane, M. A., Uras, I. Z., Hoermann, G., Nijman, S. M. B., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008292 · Cited by 82
Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention
Umar, A., Steele, V. E., Menter, D. G., & Hawk, E. T. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.010 · Cited by 82
Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms
Chen, X., Shi, X., Zhao, C., Li, X., Lan, X., Liu, S., Huang, H., Liu, N., Liao, S., Zang, D., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2361 · Cited by 82
The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells
O’Donnell, E. F., Kopparapu, P., Koch, D. C., Jang, H. S., Phillips, J. L., Tanguay, R. L., Kerkvliet, N. I., & Kolluri, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040926 · Cited by 81
Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth
Gil‐Ad, I., Shtaif, B., Levkovitz, Y., Nordenberg, J., Taler, M., Korov, I., & Weizman, A. (2006) · Oncology Reports · doi:10.3892/or.15.1.107 · Cited by 79
Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases
Pan, M., Chang, H., & Hung, W. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.004 · Cited by 79

Flagged first, then by citations

7 of the 333 references couldn’t be matched to a known paper.

Sorted by citations

The updated landscape of tumor microenvironment and drug repurposing
Jin, M.-Z., & Jin, W.-L. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00280-x · Cited by 1,262
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 544
Old Drugs as New Treatments for Neurodegenerative Diseases
Durães, F., Pinto, M. M. M., & Sousa, E. (2018) · Pharmaceuticals · doi:10.3390/ph11020044 · Cited by 362
Polytherapy and Targeted Cancer Drug Resistance
Chatterjee, N., & Bivona, T. G. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.02.003 · Cited by 277
Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers
Chen, W., Yang, W. L., Chen, P., Huang, Y., & Li, F. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14940 · Cited by 155

See all 333

Authors: Sleire, L., Førde, H. E., Netland, I. A., Leiss, L., Skeie, B. S., & Enger, P. Ø.
Affiliations: University of Bergen (NO)
Haukeland University Hospital (NO)
Corresponding author: Enger, Per Øyvind
ORCID: Leiss, Lina
Skeie, Bente Sandvei
Venue: Pharmacological Research
Publisher: Elsevier BV
Published: 2017-10
Volume: 124
Pages: 74-91
ISSN: 1043-6618 (ISSN-L)
DOI: 10.1016/j.phrs.2017.07.013
OpenAlex: W2734327577
Cited by: 329
References: 333
Citations by year: 2026: 18 · 2025: 21 · 2024: 54 · 2023: 43 · 2022: 45 · 2021: 45 · 2020: 56 · 2019: 24 · 2018: 20 · 2017: 3
FWCI: 4.63
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Pharmacological Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: drug repurposing, cancer, anticancer agents, FDA-approved drugs, anticancer mechanism, cancer prevention, unmet medical needs, anticancer drug development
MeSH terms: Animals, Antineoplastic Agents, Humans, Neoplasms, Drug Repositioning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug repurposing in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks